▼ RSI OverboughtRSI 73.1, above 70, stock may be overbought
About Globe Life Inc.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. With a market capitalization of $14.33B, it sits in large-cap territory. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments.
Premium feature
News & analytics is part of Premium.
Every headline runs through our finance-grade sentiment engine, so you see the mood of the market on each ticker before you read a single article. Plus the full analyst consensus and target-price upside, refreshed daily.
Per-headline sentiment, scored by a finance-tuned model
See exactly where the price sits versus its 150-day moving average, the live RSI reading, MACD momentum, and volume context, for any ticker, every day.
Globe Life Inc. carries $3.26B in total debt against $439.0M in cash reserves — debt is roughly 7.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $1.32B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 20.5% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.3% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $5.23B to $5.99B.
GL's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Globe Life Inc. and its sector.